Jazz Pharmaceuticals buys biotechnology firm Cavion for £259m

This article was originally published here

As per terms of the deal, the former Cavion shareholders have secured an upfront payment of $52.5m (£43.5m). They are also eligible to receive additional payments of around

The post Jazz Pharmaceuticals buys biotechnology firm Cavion for £259m appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply